BioLargo Launches Its Own barebird Brand, Reuniting Team Behind Pet Odor Control Success

Important Disclosures:

1. BioLargo Inc. is a billboard sponsor of Streetwise Reports. The company pays a monthly sponsorship fee of US$3,000–US$6,000 for banner advertising and an enhanced company profile page. Streetwise Reports’ editorial content is fully independent and is not influenced by sponsorship.
2. As of the date of this article, officers, contractors, shareholders, and/or employees of Streetwise Reports LLC (including members of their household) own securities of BioLargo Inc., Clyra Medical Technologies, and Amazon.com Inc.
3. Steve Sobek wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.
4. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
5. This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice. 

For additional disclosures, please click here.

1. Ownership and Share Structure Information

Ownership percentages, named holders, share count, market capitalization, and the 52-week range for BioLargo were compiled from the company's public filings and investor materials, exchange notices, insider-trade reports (SEDI / equivalent), and third-party data providers. Figures are as of 2026-10-29 unless a source was dated earlier. Pie slices are normalized to 100% of basic shares outstanding; retail is the residual after disclosed institutions, management, insiders, and strategic holders. Warrant terms are current outstanding series only. Restructures are historical consolidations, splits, and symbol or name changes. Insider buying and selling covers open-market trades from 2026-04-29 through 2026-10-29 and excludes option exercises. These are public-source estimates and can differ from a later official register.

• BioLargo launched barebird™, a consumer brand it owns, on October 28, built on its CupriDyne odor-elimination technology. CupriDyne removes odors through oxidation rather than masking them with fragrance.
• With barebird, BioLargo owns the brand as well as its CupriDyne technology. CEO Dennis Calvert said, "The chemistry is the star, not the brand."
• The first products are fragrance-free pet and laundry odor eliminators, available now at barebird.com, with Amazon and TikTok Shop storefronts to follow.
• The launch reunites marketing teams that helped build the original Pooph, whose CupriDyne-based products generated more than US$125 million in sales. The company notes these are historical results, not projections for barebird.
• Subsidiary ONM Environmental, which has made CupriDyne-based products since 2009, will oversee production, and BioLargo CPG, which holds an exclusive consumer license for CupriDyne, plans to add more household products, including stain removers.
• Oak Ridge Financial's Richard Ryan has a Buy rating, citing BioLargo's "hub and spoke" model of commercializing technologies through subsidiaries. 
• U.S. pet industry spending is projected to reach US$165 billion in 2026, and the global pet odor control and cleanup market is forecast to grow to US$19.33 billion by 2034.

BioLargo Inc. (BLGO:OTCQX) is back in the consumer odor market with barebird™, a brand it owns outright. The brand is built on BioLargo's CupriDyne odor-elimination technology, the same technology behind the Pooph brand of pet products. Products are available now at barebird.com, with Amazon.com Inc. (AMZN:NASDAQ) and TikTok Shop storefronts to follow, according to the company's October 28 release.

The barebird.com site went live October 30; the company and President and CEO Dennis Calvert described the launch as "really a re-launching of a great product."

"Our barebird story is one of restoring; integrity, safety, performance and value in these and other products for our customers," he told Streetwise Reports. "We're relaunching because the product's simply that good and customers have always loved it, and we believe they will love it again!"

The initial lineup includes two fragrance-free, 32-ounce products. The barebird Pet Odor Eliminator targets common household pet odors, and the barebird Laundry Odor Eliminator is a 16-load additive for clothing, towels, and bedding. Two product bundles are also planned.

In the past, BioLargo acted as a supplier for Pooph. Pooph products generated more than US$125 million in sales of CupriDyne-based products, and BioLargo recognized more than US$20 million in revenue under its supply agreement, according to the company. Pooph's advertising ranked as the No. 1 direct-response TV campaign of 2023 in the SciMark Report's True Top 50 rankings, and the brand reported distribution in nearly 40,000 retail stores by early 2025. BioLargo notes these are historical results, not projections for barebird.

That relationship ended in September 2025, when BioLargo revoked Pooph's technology license, citing about US$3.8 million in unpaid amounts, according to a company release. "Our science has been validated in the marketplace at scale," Calvert said at the time.

With barebird, BioLargo now owns the brand as well as the technology. Calvert said what made Pooph work was our CupriDyne formula, not the name on the bottle. "It's not the brand," he said. "It's the chemistry inside that makes it work."

"The chemistry is the star, not the brand," he added.

He said the company is "seeking to enter into a market and recapture our goodwill," and that the focus is on the people who use the product. "The customers deserve the best," he said.

"By owning the brand, we are in control of the marketing, messaging and organizational infrastructure," Calvert said in the November 3 release.

The marketing teams that helped build the Pooph line have reunited for the barebird launch. Where Pooph relied heavily on direct-response TV ads and a fast retail rollout, barebird will lean on digital media, social platforms, influencers, affiliate marketing, and selling directly to consumers, the company said. It said that approach lets it test its messages and track what it costs to win each customer.

BioLargo subsidiary ONM Environmental, which has made CupriDyne-based products since 2009, will oversee production through its manufacturing arrangements, including co-packers. barebird is the first brand from BioLargo CPG LLC, which holds the exclusive license to use CupriDyne in consumer packaged goods, according to the November 3 release. That structure could allow outside investors to put money directly into the consumer business, the company said.

Oak Ridge Financial analyst Richard Ryan reaffirmed his "Buy" rating on BioLargo in an August 19 report. 

"We are starting with two products that previously demonstrated strong demand and repeat purchasing," said BioLargo CPG President and CEO Joe Provenzano.

CupriDyne removes odors through oxidation rather than masking them with fragrance. Calvert described the chemistry simply. "It's a safe and easy to use iodine and copper solution," he said. "When it comes in contact with an organic odor compound, it's going to break it down. That's it. That's what it does." The brand sums up its fragrance-free approach with the tagline "Smells like nothing. On Purpose."

BioLargo CPG plans to add more household odor and cleaning products later, possibly including stain removers, the company said. Over time, it said, the brand could also expand internationally through distribution and licensing deals, though that will depend on execution, financing, and market development.

BioLargo describes itself as a cleantech and life sciences innovator and engineering services solution provider. Its products address PFAS contamination, water and wastewater treatment, odor and VOCs, air quality, energy efficiency and storage, and infection control. The company runs that work through a set of subsidiaries, according to its April S-1 filing.

ONM Environmental, which is wholly owned, handles odor and VOC control, selling CupriDyne Clean and private-label products to industry. BioLargo Equipment Solutions & Technologies (BEST), also wholly owned, sells water treatment products, including the AEC PFAS treatment system and AROS water reuse technology. BioLargo Canada, another wholly owned unit, is the company's primary research and development team, based at the University of Alberta in Edmonton, and has recently formed a joint venture called T Nipi, which is headed up by a team of First Nation members and is now developing business in the oil field services market in Alberta, Canada, focused on Oil Sands tailings pond water treatment.

BioLargo owns 95% of BioLargo Energy Technologies, which is developing the Cellinity liquid sodium battery for energy storage, and 70% of BioLargo Engineering, Science & Technologies (BLEST), a professional engineering services firm in Oak Ridge, Tennessee. It also holds a 48% stake in Clyra Medical Technologies, which makes medical device products with ViaCLYR, its FDA 510(k)-cleared wound irrigation solution now being sold into the market for wound and burn care.

The company said its PFAS treatment business is in early commercial activity, as regulations and litigation against polluters are gaining traction around the world, with longer-term growth depending partly on regulation, customer demand, and available funding, and that its Cellinity energy storage technology is at an earlier stage.

Oak Ridge Financial analyst Richard Ryan reaffirmed his "Buy" rating on BioLargo in an August 19 report.

He described the company's business model as "a hub and spoke format," in which BioLargo invents or acquires a product, proves it out, partners with third parties, and then commercializes it. Running its technologies through operating subsidiaries, he wrote, "diversifies overall risk, maintains high levels of segment ownership while providing solutions to diversified, high-growth end markets."

Americans keep spending more on their pets. U.S. pet industry spending reached US$158 billion in 2025, up 3.7%, and is projected to hit US$165 billion in 2026, according to the American Pet Products Association (APPA). About 95 million U.S. households now own at least one pet. Dog ownership rose to 53% of households, or 71 million, and the number of cat-owning households rose 5% from a year earlier to 53 million. APPA President and CEO Pete Scott called the pet industry "a healthy, evolving market."

More pets in more homes means more cleanup. The global market for pet odor control and cleanup products is projected to grow from US$15.07 billion in 2026 to US$19.33 billion by 2034, a compound annual growth rate of 3.16%, according to Fortune Business Insights. North America accounted for 51% of the market in 2025, and the U.S. alone held nearly 38% of global sales.

The firm said demand is being driven by rising pet ownership, more pets living indoors, especially in cities, and growing hygiene awareness as owners treat pets like family. Buyers are also willing to pay more for higher-quality cleaners, and the market is shifting toward natural and biodegradable formulas. The main obstacle is cheap do-it-yourself fixes such as vinegar and baking soda.

What is barebird?

barebird is BioLargo's new company-owned consumer brand, built on its CupriDyne odor-elimination technology and run through the BioLargo CPG unit. The first lineup includes a pet odor eliminator, a laundry odor eliminator, and two bundles.

How does barebird relate to Pooph?

Pooph's products were also built on CupriDyne and generated more than US$125 million in sales, and BioLargo recognized more than US$20 million in revenue under its supply agreement. BioLargo revoked Pooph's technology license in September 2025, citing unpaid amounts. barebird reunites marketing teams that helped build Pooph, but this time BioLargo owns the brand. The company notes that Pooph's results are historical, not projections for barebird.

When will barebird products be available?

Products are available now at barebird.com, with Amazon and TikTok Shop storefronts to follow.

How does CupriDyne work?

CupriDyne removes odors through oxidation rather than masking them with fragrance.

What's next for BioLargo's consumer business?

BioLargo CPG plans to add more household odor and cleaning products after the first pet and laundry lineup, possibly including stain removers. The company said the brand could also grow internationally through distribution and licensing deals over time.

What else does BioLargo do?

Through its subsidiaries, BioLargo works on PFAS contamination, water and wastewater treatment, odor and VOC control, air quality, energy storage, and infection control. That includes Clyra Medical Technologies' FDA 510(k)-cleared ViaCLYR wound irrigation solution.

What are analysts saying?

Oak Ridge Financial's Richard Ryan reaffirmed his Buy rating in August, citing BioLargo's "hub and spoke" model.